| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.03B | 17.00B | 15.26B | 14.12B | 12.35B | 10.73B |
| Gross Profit | 8.26B | 9.87B | 8.28B | 7.08B | 5.83B | 4.12B |
| EBITDA | 5.81B | 6.31B | 5.44B | 5.36B | 3.76B | 3.30B |
| Net Income | 2.54B | 4.20B | 2.54B | 2.83B | 2.29B | 1.89B |
Balance Sheet | ||||||
| Total Assets | 41.42B | 50.98B | 42.03B | 33.53B | 25.13B | 18.42B |
| Cash, Cash Equivalents and Short-Term Investments | 3.81B | 3.58B | 3.92B | 4.23B | 6.88B | 5.78B |
| Total Debt | 10.41B | 12.64B | 10.07B | 5.22B | 3.86B | 3.05B |
| Total Liabilities | 21.24B | 25.34B | 21.05B | 18.34B | 13.26B | 9.28B |
| Stockholders Equity | 14.05B | 19.12B | 15.53B | 11.57B | 9.62B | 7.50B |
Cash Flow | ||||||
| Free Cash Flow | 6.50M | -1.79B | -551.00M | -5.20B | -2.69B | 1.05B |
| Operating Cash Flow | 145.50M | 4.58B | 704.00M | -574.00M | 2.64B | 3.58B |
| Investing Cash Flow | -174.00M | -6.92B | -2.54B | -4.74B | -5.51B | -2.66B |
| Financing Cash Flow | 61.50M | 1.87B | 1.38B | 2.31B | 3.58B | 1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥544.53B | 22.14 | 15.67% | 1.31% | 9.02% | 21.15% | |
73 Outperform | ¥16.97B | 12.14 | ― | 3.53% | 3.36% | -23.59% | |
71 Outperform | ¥46.33B | 11.01 | ― | 1.28% | 11.37% | 63.62% | |
66 Neutral | ¥16.57B | 49.40 | ― | 1.01% | 14.48% | -12.25% | |
65 Neutral | ¥8.80B | 8.93 | ― | 3.85% | -6.67% | 34.46% | |
63 Neutral | ¥19.02B | 25.02 | ― | ― | 25.92% | -10.51% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |